- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00615277
The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood
The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood of Healthy Young Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The long-chain polyunsaturated fatty acids (LCPUFA) EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) of the omega-3 series and AA (arachidonic acid) of the omega-6 series are building blocks of all cell membranes and are found in high concentrations in retina and brain. Food sources of LA and ALA are vegetable oils, nuts and seeds. Since low conversion rates from ALA to DHA are a characteristic of human metabolism, adequate dietary provision with the long-chained omega-3 molecules depends primarily on individual eating habits. While AA is abundant in meat and dairy products, EPA and DHA are found in noteworthy concentrations only in certain species of fatty fish, such as salmon or mackerel.
The study investigates whether participants receiving an omega-3 supplement over a period of 4 month, perform better on a series of cognitive tests, than the participants allocated to the placebo group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy young adults
Exclusion Criteria:
- Coagulation disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
1: omega-3 fatty acid supplement
|
600 mg EPA 120mg DHA daily, 16 weeks
|
|
Placebo Comparator: 2
2: olive oil
|
600 mg EPA 120mg DHA daily, 16 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cognition
Time Frame: Before intervention and after 16 weeks of intervention
|
Before intervention and after 16 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mood
Time Frame: Before intervention and after 16 weeks of intervention
|
Before intervention and after 16 weeks of intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Katharina A Widenhorn-Mueller, PhD, University of Ulm
- Principal Investigator: Ulrike Weiland, MD, University of Ulm
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 213/2005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.